Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PSSR: Primary Surgery vs Preoperative Radiochemotherapy for Rectal Cancer
NCT02121405Phase 3Suspended
- Sponsor
- Zhejiang University
- Start
- Oct 2015
- Primary completion
- Feb 2024
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in rectal cancer (2 arms), sponsored by Zhejiang University. Primary endpoint: Disease-Free Survival at 3 years. Started Oct 2015; status: suspended.
02
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT02121405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02121405.